Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 22 filings·Updated 26 Sept 2026
Showing 10 of 22 filings.
26 Sept 20261 filing
Insider Trading / SASTClosure of Trading Window

Hamps Bio Limited — Trading window closed from 1st October, 2026 till 48 hours after the announcement/declaration of unaudited Standalone and Consolidated Financial Results of the Company for half year ended on 30th September, 2026.

Hamps Bio Limited — Trading window closed from 1st October, 2026 till 48 hours after the announcement/declaration of unaudited Standalone and Consolidated Financial Results of the Company for half year ended on 30th September, 2026.

Filed 16:34View Source
11 Sept 20261 filing
AGM/EGMAGM

Hamps Bio Ltd’s 19th AGM approves financials, director re-appointment, and registered office shift.

AGM Details

  • Date and time: 9 September 2026, 12:00–13:00; physical AGM at registered office.
  • Mode: Physical meeting.
  • Record date: 3 September 2026.
  • Postal ballot deadline: 9 September 2026.
  • Shareholders on record: 337; attendees: promoters 9, public 2; no video attendees.

Resolutions & outcomes

  • Adopt audited standalone and consolidated financial statements for FY ended 31 March 2026.
  • Re-appoint Pallavi Herrik Shah as director; retires by rotation.
  • Approve shifting of registered office within Gujarat under the same registrar.
  • All resolutions passed with 100% votes in favour.

Dividend

  • No dividend declared at the AGM.

Director changes

  • Pallavi Herrik Shah re-appointed as director.
  • No other director changes disclosed.

Auditors

  • No auditor appointments or changes disclosed.

Material related party transactions

  • No material related party transactions disclosed.

Other material approvals

  • Shift of registered office approved.
Filed 11:37View Source
9 Sept 20262 filings
OthersOutcome without intimation

HAMPS BIO approves remuneration increases for four executives at Sep 9, 2026 board meeting

Remuneration approvals

  • Remuneration increase approved for Herrik Mountbaton Shah, Chairman and Managing Director, per Nomination and Remuneration committee recommendation.
  • Remuneration increase approved for Shrenikkumar Mountkumar Shah, Whole Time Director, per Nomination and Remuneration committee recommendation.
  • Remuneration increase approved for Mitali Shrenikkumar Shah, Chief Financial Officer, per Nomination and Remuneration committee recommendation.
  • Remuneration increase approved for Pallavi Herrik Shah, Director, per Nomination and Remuneration committee recommendation.
Filed 18:14View Source
AGM/EGMAGM

Hamps Bio Ltd conducts 19th AGM; approves financial statements, director re-appointment, and shifts registered office

AGM Details

  • Date and time: 09 September 2026 at 12:00 PM IST; physical meeting at registered office.
  • Meeting concluded at 01:00 PM IST.
  • Remote e-voting available; ballot papers provided at the meeting.

Ordinary Business

  • Adopt audited standalone and consolidated financial statements for the year ending 31 March 2026.
  • Re-appointment of Pallavi Herrik Shah, who retires by rotation.

Special Business

  • Approve shifting of registered office within Gujarat under the same RoC.

Voting/Results

  • Results of voting to be announced to stock exchange and placed on the company website.
Filed 17:20View Source
17 Aug 20262 filings
OthersReg. 34 (1) Annual Report

Hamps Bio Limited FY2025-26: revenue growth amid net losses, consolidation of subsidiary and brand-led strategy

Financials

  • Standalone revenue from operations: ₹851.65 lakhs.
  • Consolidated revenue from operations: ₹847.46 lakhs.
  • Standalone net loss after tax: ₹65.49 lakhs.
  • Consolidated net loss after tax: ₹73.87 lakhs.
  • Standalone EPS: ₹-0.75 per share.
  • Dividend not declared for FY2025-26.

Operations & Capacity

  • Ankleshwar and Bhatpore facilities strengthened; Surat production now full-fledged.
  • Surat freeze-drying capacity added: 450 kg/day.
  • 350 kVA solar power plant commissioned at Ankleshwar.
  • Kosher certification obtained for Ankleshwar facility.
  • Capacity utilization ~18 tons/month per plant (22 installed).

Capital & Dividends

  • Bonus issue: 4,356,000 shares (1:1).
  • Authorized capital increased to ₹10 crore.
  • Paid-up capital ₹8.712 crore.

Governance & Board

  • Radhika Kanodiya resigned as Independent Director on 23 Jun 2025.
  • Shivali Rajpurohit appointed as Additional Director on 25 Aug 2025.
  • Shivali Rajpurohit regularised as Independent Director on 24 Nov 2025.
  • Pallavi Herrik Shah to be re-appointed as Director.
  • Board met 10 times in FY2025-26; committees formed and reconstituted.

Strategy & Growth

  • Strategic shift from manufacturing to consumer brands.
  • Focus on FzyEzy and OxyNXT brands.
  • Export expansion and international markets focus.

Risks & Outlook

  • Risks include raw material price volatility and currency fluctuations.
  • Tariffs/regulatory changes affecting exports pose risk.
  • Seasonality of agricultural inputs may impact volumes.

Related Party Transactions

  • Related party transactions disclosed; director remuneration and loans.
  • Transactions with HSDL, V4U Healthcare, Adinath, Mahavir, and others.
Filed 19:45View Source
AGM/EGMAGM

Hamps Bio to hold 19th AGM on 9 September 2026 at registered office (in-person)

AGM Details

  • AGM on 9 September 2026 at 12:00 PM at the registered office; mode: in-person.
Filed 19:23View Source
12 Aug 20261 filing
OthersOutcome without intimation

HAMPS BIO approves annual report, AGM notice, and director re-appointment; shifts registered office within Gujarat; scrutineer appointed

Key Decisions

  • Approved Board Report for FY ended 31 March 2026.
  • Approved the 19th AGM notice for FY2026 on Sept 9, 2026 at 12:00.
  • Approved draft Annual Report for FY2026.
  • Recommended ordinary resolution for re-appointment of Pallavi Herrik Shah.
  • Shifting of registered office from Ankleshwar to Surat within Gujarat; subject to AGM approval.
  • Appointed M/s Richa Goyal & Associates as Scrutinizer for AGM voting.
  • Fixation of Cut-off Date for eligibility to vote on AGM resolutions.
Filed 18:47View Source
14 Jul 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Reg 74(5) certificate shows no demat/remat requests; Regulation not applicable as all shares are in demat

Demat/remat status

  • No dematerialisation/rematerialisation requests were received during the quarter ended 30 June 2026.
  • Regulation not applicable as the entire holding is in demat form.
Filed 15:46View Source
6 Jul 20262 filings
Company UpdateGeneral

Hamps Bio discloses current Key Managerial Personnel for materiality determinations and disclosures

Key Managerial Personnel

  • MD Herrik Mountbaton Shah designated Managing Director; contact details provided.
  • Shrenikkumar Mountkumar Shah designated Whole-time Director.
  • Mitali Shrenikkumar Shah designated Chief Financial Officer.
  • Ravi Baheti designated Company Secretary and Compliance Officer.
  • Contact details include email hamps.bio@gmail.com and phones 8000001113, 8000006663.
  • Registered office Bharuch and corporate office Surat details.
Filed 18:24View Source
Company UpdateAppointment of Company Secretary / Compliance Officer

Hamps Bio Limited appoints Ravi Baheti as Company Secretary and Compliance Officer

Appointment Details

  • Appointee: Ravi Baheti as Company Secretary and Compliance Officer.
  • Effective date: 6 July 2026.
  • Reason for change: appointment to fill the CS & CO vacancy.
  • Profile: ICSI Associate, Membership No. A49472; B.Com (Hons); 9+ years' governance experience.
  • Experience: 9+ years in secretarial, governance, and compliance management.
  • Relationship with directors/promoters: none/not applicable.
  • Governance role: board authorised KMPs to determine materiality for disclosures.
Filed 18:20View Source
Showing 10 of 22 filings